medical parasitology

93
MEDICAL PARASITOLOGY HELMINTHS & PROTOZOA

Upload: wilma

Post on 14-Jan-2016

56 views

Category:

Documents


2 download

DESCRIPTION

MEDICAL PARASITOLOGY. HELMINTHS & PROTOZOA. INFORMATION EMPHASIS. Agent and Group ID; general importance Epidemiology (distribution, transmission, etc) Pathogenic capability Diagnosis Control. BASIC TERMINOLOGY & PRINCIPLES. Symbiosis: Living together - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: MEDICAL PARASITOLOGY

MEDICAL PARASITOLOGY

HELMINTHS & PROTOZOA

Page 2: MEDICAL PARASITOLOGY

INFORMATION EMPHASIS• Agent and Group ID; general importance

• Epidemiology (distribution, transmission, etc)

• Pathogenic capability

• Diagnosis

• Control

Page 3: MEDICAL PARASITOLOGY

BASIC TERMINOLOGY & PRINCIPLES

• Symbiosis: Living together

• Commensalism: One symbiont benefits, other unaffected

• Mutualism: Both symbionts benefit

• Parasitism: One symbiont benefits, other is damaged

Page 4: MEDICAL PARASITOLOGY

COMMON TERMS

• Obligate vs Facultative Parasites

• Endo- vs Ecto-parasites

• Pseudo- vs Spurious Parasites

• Zoonotic Parasites

• Host-specific vs Non-host-specific Parasites

• Definitive vs Intermediate Hosts

• Paratenic/Transfer Hosts

• Vectors

Page 5: MEDICAL PARASITOLOGY

PARASITE SURVIVAL FACTORS

• Parasites have successfully adapted to (all?) environmental “niches” in hosts

• Parasites best adapted are least pathogenic

• Parasite-host relationships are typically long-term/chronic/”intimate”

Page 6: MEDICAL PARASITOLOGY

CONDITIONS NECESSARY FOR SUCCESSFUL ENDEMIC PARASITISM

• Reservoir of infection

• Means of transmission from infected to susceptible, “new” hosts

• Ability to invade and successfully reside in “new” hosts

• Ability to reproduce

Page 7: MEDICAL PARASITOLOGY

HELMINTH/WORM TERMINOLOGY• Adults: sexually reproductive life cycle stage• Larvae: developmental or asexually

reproductive life cycle stage• Eggs: stage protective of zygote &/or embryo• Cysts: usually a larval stage encapsulated in

tissues of an intermediate host • Hypobiosis: worms in temporary developmental

arrest• Monoecious/hermaphroditic: both sexes 1 body• Dioecious: sexes separate; males & females• Parthenogenesis: ability to produce offspring

without fertilization of eggs

Page 8: MEDICAL PARASITOLOGY

Helminths, continued

Worm-terms, continued

• Oviparous: production of eggs, discharged from uterus of female

• Ovoviviparous: production of eggs which hatch prior to discharge from uterus of female

• Viviparous: production of embryos/L1 larvae, no rigid encapsulation of embryo

Page 9: MEDICAL PARASITOLOGY

Enteric helminths, continued

GENERALIZED NEMATODE LIFE CYCLE

AdultsEggs Embryos L1

L2 larva

L3 larva

L4 larva

L5 juvenile

Page 10: MEDICAL PARASITOLOGY

Enteric Helminths

Ascaris lumbricoides

• SI roundworm transmitted fecal-oral via eggs

• Pathogenic potential low to high, depending on host species and condition, number of eggs ingested, secondary bacterial agents carried

• Clinical signs: larval migration; none, pneumonitis, asthmatic reaction. Adults; SI blockage, plugging of bile duct, perforation of SI, appendix or other site, malnourishment

• Reservoir: human DH

• Damage potential: dependent on worm #s, host susceptibility to larval and adult action

Page 11: MEDICAL PARASITOLOGY

Enteric helminths, continued

A. lumbricoides, continued

• Prevalence: world-wide, temperate and tropical regions, possibly 1 billion infected

• Diagnosis: eggs in feces, observation of ‘drop-out’ adult worms

• Treatment: piperazine, albendazole, mebendazole, pyrantel pamoate

Page 12: MEDICAL PARASITOLOGY

Enteric helminths, continued

Ascaris lumbricoides life cycle

Page 13: MEDICAL PARASITOLOGY

Extra-enteric helminths, continued

Toxocara canis, Toxocara cati, Balisascaris columnaris, others (Visceral Larval Migrans)

• Transmission: fecal-oral, ingestion of infective ova

• Pathogenic potential high, dependent on #s of larvae, migrational destination(s)

• Clinical signs determined by #s of larvae, sites infected; cough, fever, hypereosinophilia, retinochoroiditis, epilepsy, myocarditis, other

• Reservoir hosts: canines, felines, mustelids, raccoons, badgers, oppossums, other

• Damage potential high: carriers of bacterial contaminants, direct toxicity & tissue destruct.

Page 14: MEDICAL PARASITOLOGY

Extra-enteric helminths, continued

T. canis, T. cati, B. columnaris, et.al.

• Prevalence worldwide, sanitation dependent, cold/cool temperate regions to equator

• Diagnosis: serology, lesion/abcess pathological examination (gross & histo), high eosinophil count is strongly suggestive

• Treatment: systemic anthelmintics have been used with varying degrees of success, depending on diagnostic timing; fenbendazole & other benzimidazoles, probably avermectins

Page 15: MEDICAL PARASITOLOGY

Toxocara canis life cycle

Page 16: MEDICAL PARASITOLOGY

Enteric helminths, continued

Ancylostoma duodenale & Necator americanus (hookworms)

• Transmission via contact of skin with L3 larva• Pathogenic potential: population dependent, each

worm sucks blood from mucosa in SI, larval migration usually insignificant

• Clinical signs: minor reaction (ground itch), # dependent, at larval entry; pneumonitis via migrating larvae, if large #s; eosinophilia, occult blood in stools, diarrhea, anemia, edema, et.al.

• Reservoir: humans, possibly other anthropoids• Damage potential depends on condition & sensitivity

of host, and #s of worms

Page 17: MEDICAL PARASITOLOGY

Enteric helminths, continued

A. Duodenale & N. americanus, continued

• Prevalence world-wide, in tropics, subtropics, and warm temperate regions; some zonal variation by species

• Diagnosis by ID of ova in feces

• Treatment: albendazole, mebendazole, pyrantel pamoate, piperazine (probably)

Page 18: MEDICAL PARASITOLOGY

Hookworm Life Cycle

Page 19: MEDICAL PARASITOLOGY

Extra-enteric helminths, continued

Ancylostoma caninum, A. braziliense, Uncinaria stenocephala, et.al. (cutaneous larval migrans)

• Transmission: penetration of skin by direct contact with infective L3 larvae

• Pathogenic potential: low, transient

• Clinical signs: “serpiginous tracks”/”creeping eruption” on skin near invasion sites

• Reservoir hosts: canines, felines, other animals with host-specific species of hookworms

• Damage potential: limited to numbers of worms involved, host sensitivity to cutaneous trauma

Page 20: MEDICAL PARASITOLOGY

Extra-enteric helminths, continued

A. caninum, A. braziliense, U. stenocephala, et.al

• Prevalence: worldwide distribution, tropical, subtropical, warm & cool temperate, sub-arctic (Uncinaria)

• Diagnosis: visual observation of characteristic “tracks/burrows” on skin surface

• Treatment: albenazole, other benzimidazoles

Page 21: MEDICAL PARASITOLOGY

Enteric helminths, continued

Trichuris trichiura (whipworm)• Transmission: fecal-oral via embryonated ova• Pathogenic potential: low to moderate, dependent on

worm numbers & location in LI• Clinical signs: dependent on worm #s; none,

bloody(frank)/mucoid diarrhea, abdominal pain & distention, rect. prolapse, anemia, weakness, eosinophilia

• Reservoir: mainly human, others possible but host specificity not well documented

• Damage hinges on results & numbers of worm mucosal perforations, bacterial/viral involvement, degrees of blood loss, worm location

Page 22: MEDICAL PARASITOLOGY

Enteric helminths, continued

T. trichiura, continued

• Prevalence: worldwide tropical, subtropical, warm temperate sanitation dependent; SE USA, spotty in other states with large populations of infected immigrants

• Diagnosis: microscopic ID of ova in feces

• Treatment: albendazole is drug of choice

Page 23: MEDICAL PARASITOLOGY

Trichuris trichiura life cycle

Page 24: MEDICAL PARASITOLOGY

Enteric helminths, continued

Capillaria phillipinensis

• Transmission: ingestion of larvae in fresh and brackish-water fish

• Pathogenic potential high due to worm site and autoinfection factors

• Symptoms: abdominal pain, borborygmus, diarrhea early; anorexia, nausea, vomiting, et.al

• Reservoir unknown: probably many fish-eating mammals

• Damage potential high: populations build via autoinfection; adults and larvae migrate through mucosal tissue in (mainly) jujunal SI

Page 25: MEDICAL PARASITOLOGY

Enteric helminths, continued

C. phillipinensis, continued

• Prevalence high/moderate in Phillipine areas where eating raw fish is a cultural event

• Diagnosis: microscopic ID of ova in feces, differentiation from whipworm eggs (Trichuris)

• Treatment: mebendazole drug of choice, other benzimidazoles also efficacious

Page 26: MEDICAL PARASITOLOGY

Enteric helminths, continued

Enterobius vermicularis (pinworm)

• Transmission by ingestion of embryonated ova

• Pathogenic potential 0/low

• Clinical signs: occasional anal itching from night-time exit migration of female worm for oviposition; occasional host skin pruritis to egg ‘glue’; rare migration & disintegration of female worms into urogenital tract of female, with lesions in abdominal cavity via oviducts

• Reservoir hosts human (family & friends)

• Damage potential 0; no tissue invasion/insult, no apparently toxic by-product production

Page 27: MEDICAL PARASITOLOGY

Enteric helminths, continued

E. vermicularis, continued

• Prevalence world-wide, arctic to equator

• Diagnosis: microscopic ID of ova &/or worms on transparent cellophane tape swab of perineum

• Treatment: albendazole, and others

Page 28: MEDICAL PARASITOLOGY

Enterobius vermicularis life cycle

Page 29: MEDICAL PARASITOLOGY

Extra-enteric HelminthsStrongyloides stercoralis• Transmission: ingestion of, or skin contact with

L3 larva, possibly congenital & transmammary• Pathogenic potential very high due to

autoinfection, infection site, parasite-host incompatibility

• Clinical signs: skin reaction at larval entry (ground itch), pneumonitis re primary larval migration, diarrhea/dysentery, malabsorption, mucosal ulceration, frank or occult bloody stool

• Reservoir hosts: none necessary, free-living agent with invasion capability (facultative P)

Page 30: MEDICAL PARASITOLOGY

Extra-enteric helminths, continued

S. stercoralis, continued

• Damage potential high/extreme: direct damage to SI villar epithelium extensive; worm population buildup intensifies, eventually colonizes colonic mucosa, nutritional absorption restricted/eliminated, dehydration intense

• Prevalence: free-living colonies numerous, distribution similar to hookworms, human infections rare, sporadic, but significant

• Diagnosis; isolation, microscopic ID of ova, larvae in feces or intestinal biopsies

• Treatment: albendazole, ivermectin, others

Page 31: MEDICAL PARASITOLOGY

Strongyloides stercoralis life cycle

Page 32: MEDICAL PARASITOLOGY

Extra-enteric helminths, continued

Trichinella spiralis

• Transmission: ingestion of encysted larvae in meat

• Pathogenic potential: moderate in majority of infected hosts; # of infective larvae, host tolerance are major factors

• Clinical signs: occasional diarrhea during early stages; fever, eosinophilia, muscle pain/stiffness during larval invasion of muscle

• Damage potential: low/moderate in ‘healthy’ hosts, high in those in which myocarditis, encephalitis or chronic pneumonitis occur

Page 33: MEDICAL PARASITOLOGY

Extra-enteric helminths, continued

T. spiralis, continued

• Prevalence: low to high, dependent on cultural preferences regarding meat selection & preparation; no climatic factors are involved

• Diagnosis: serologic testing, histologic ID of larvae in muscle biopsy

• Treatment: corticosteroids, mebendazole, albendazole

Page 34: MEDICAL PARASITOLOGY

Trichinella spiralis life cycle

Page 35: MEDICAL PARASITOLOGY

Extraenteric helminths, continued

Dracunculus medinensis

• Transmitted by ingestion of copepod IH

• Clinical signs: skin “blister” followed by ulcer with anterior end of female worm visible, cutaneous bulge of skin over body of worm, various immune responses (rashes, asthma)

• Reservoir hosts: canines, many other mammals

• Damage potential: low to moderate, depending on sensitivity of host to worm excretions and other worm-related antigens

• Prevalence worldwide, from equator into cool temperate climatic areas

Page 36: MEDICAL PARASITOLOGY

Extraenteric helminths, continued

D. medinensis, continued

• Diagnosis: observation of skin ulcer, at bottom of which end of female worm is visible

• Treatment: removal of worm by gentle extraction from burrow by winding on a stick, with concomitant use of metronidazole or thiabendazole

Page 37: MEDICAL PARASITOLOGY

Dracunculus medinensis life cycle

Page 38: MEDICAL PARASITOLOGY

Filarid helminths

Filarid Helminth Life Cycle

DH Vector

Adults microfilariae L1 L2 larva

L4 larva L3 larva

L5 larva

Page 39: MEDICAL PARASITOLOGY

Filarid helminths

Wuchereria bancrofti (filariasis/elephantiasis)• Transmission by mosquito vectors• Pathogenic potential moderate - high, long term• Clinical signs: variable re host factors and worm

species/strains; none, renal disease, hematuria, proteinuria, hyperimmune reactivity, eosinophilia, lymphangitis (soft edematous swelling of extremeties, followed by eventual hardening)

• Reservoir hosts: humans, some monkeys• Damage potential variable: immune reactions to

worms & worm products varies with individuals, long-term, plugging of lymph vessels

Page 40: MEDICAL PARASITOLOGY

Filarid helminths, continued

W. bancrofti, continued

• Prevalence: throughout tropical and subtropical countries, into some warm temperate areas

• Diagnosis: recovery and microscopic ID of microfilaria from blood samples

• Treatment: diethylcarbamazine, followed by ivermectin for prevention of reinfection

Page 41: MEDICAL PARASITOLOGY

Wuchereria bancrofti life cycle

Page 42: MEDICAL PARASITOLOGY

Filarid helminths, continued

Brugia malayi, et.al.• Transmission by mosquito species different

from those involved with W. bancrofti • Pathogenic potential essentially similar to that

described for W. bancrofti• Clinical signs similar to those of W. bancrofti• Damage potential similar to that of W. bancrofti• Prevalence similar to W. bancrofti, regional

differences dependent on vector habitat preferences

• Diagnosis: microscopic diff of microfilariae from other species

• Treatment: diethylcarbamazine + Ivermectin

Page 43: MEDICAL PARASITOLOGY

Filarid helminths, continued

Loa loa (african eyeworm)• Transmission via chrysops/mango fly vectors• Pathogenic potential moderate, dependent on

host sensitivity factors• Clinical signs: eosinophilia, few obvious signs

except when adults are migrating across eye; occasional swellings, edema in local sites

• Reservoir hosts: monkeys known, possibly et.al• Damage potential low, minor host response

normally• Prevalence: tropical, rain forest vector habitat• Diagnosis: ID of microfilaria, extraction of adult• Treatment: Diethylcarbamazine + ivermectin

Page 44: MEDICAL PARASITOLOGY

Loa loa life cycle

Page 45: MEDICAL PARASITOLOGY

Filarid helminths, continued

Mansonella spp., Dipetalonema spp., et.al.• Transmission by midges & blackflies• Pathogenic potential low to zero• Clinical signs usually non-existent• Reservoir hosts: humans, monkeys• Damage potental low, dependent on host

sensitivity to specific worms• Prevalence: tropical, subtropical, warm

temperate regions where vectors exist• Diagnosis: ID of microfilariae in blood• Treatment: Diethylcarbamazine + ivermectin,

when warranted

Page 46: MEDICAL PARASITOLOGY

Filarid helminths, continued

Onchocerca volvulus (river blindness)

• Transmitted by blackfly vectors

• Pathogenic potential moderate, dependent on death & decomposition of microfilariae

• Clinical signs: adult clusters cause subcutaneous nodules, microfilariae cause blindness

• Reservoir hosts: large domestic animals, probably others

• Damage potential low/moderate, depending on host sensitivity, toxicity of worm ‘strain’, number and death/decomposition rate of larvae in eye

Page 47: MEDICAL PARASITOLOGY

Filarid helminths, continued

O. volvulus, continued

• Prevalence variable, 5 to 80% in endemic areas near streams needed by blackfly reproduction

• Diagnosis; observation of adults in prominent subcutaneous nodules, skin biopsy and histologic examination for microfilariae

• Treatment: surgical removal of adults, diethylcarbamazine, ivermectin for larvae

Page 48: MEDICAL PARASITOLOGY

Onchocerca volvulus life cycle

Page 49: MEDICAL PARASITOLOGY

Filarid helminths, continued

Dirofilaria immitis (canine heartworm infection)• Transmission by mosquito vector• Pathogenic potential in human (unnatural host)

low/moderate, dependent on host sensitivity• Clinical signs usually absent in humans, dependent on

location of worm• Reservoir hosts; canines (dogs, coyotes, etc.)• Damage potential low in humans, dependent on host

sensitivity, #s of worms, location of worms• Prevalence wide: tropical, subtropical, warm and cool

temperate regions• Diagnosis: usually biopsy of dead, encysted worm• Treatment: surgical removal

Page 50: MEDICAL PARASITOLOGY

Flatworms/PlatyhelminthsFlatworm-related Terminology• Cestodes/tapeworms: segmented flatworms• Trematodes/flukes: leaf-shaped (except for

schistosomes), single-unit flatworms• Oncosphere/hexacanth: egg-encased embryo

of cyclophyllidean tapeworms• Coracidium: egg-encased embryo of

pseudophyllidean tapeworms• Miracidium: egg-encased embryo of flukes• Cysticercoid, cysticercus, coenurus, hydatid

cysts: cyclophyllidean tapeworm larval types in IHs

Page 51: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Flatworm terms, continued

• Procercoid, plerocercoid: larvae of pseudophyllidean tapeworms

• Scolex: organ of attachment, adult tapeworms

• Proglottids: tapeworm body segments

• Strobila: tapeworm body (all segments)

• Sporocyst, redia: larvae of fluke species

• Cercaria: end stage of asexual reproduction of flukes

• Metacercaria: encysted cercaria infective to DH

Page 52: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Trematodes/Flukes

Generalized Fluke Life Cycle

Adults in DH

Egg Miracidium (embryo) Snail primary IH

Sporocyst &/or Redia larva

Cercaria

Vegetation/secondary IHMetacercaria

Page 53: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Fasciolopsis buski (intestinal fluke)• Transmission: ingestion of metacercaria on

aquatic vegetation• Pathogenic potential 0/low• Clinical signs: none, rash, intestinal discomfort• Reservoir hosts: numerous, herbivores• Damage potential: low, minor SI mucosal

damage• Prevalence: high, ~ 10 m infections annually in

oriental and asian, tropical/subtropical areas• Diagnosis: ID of eggs in fecal sedimentation• Treatment: prazyquantel, niclosamide

Page 54: MEDICAL PARASITOLOGY

Fasciolopsis buski life cycle

Page 55: MEDICAL PARASITOLOGY

Flatworm parasites, continued

Echinostoma spp. (spiny-mouthed flukes)

• Transmission: ingestion of metacercaria in snail secondary IH

• Pathogenic potential low/moderate

• Clinical signs: # dependent, none/mild irritation

• Reservoir: many snail-eating mammal DHs

• Damage potential low: some SI abrasion

• Prevalence: oriental, asian tropical/subtropical countries

• Diagnosis: microscopic ID of ova in fecal sed

• Treatment: praziquantel, niclosamide

Page 56: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Heterophyes spp., Metagonimus spp.

• Transmission: ingestion of metacercaria in fish secondary IH

• Pathogenic potential: low early, rising to high over time, re: worm #s, infection longevity

• Clinical signs: none early, myocarditis, seizures, neurologic defecits, other, in chronic infections

• Reservoir hosts: most piscivorous mammals

• Damage potential: dependent on tissue-infested ova lodged in various organs, emitting toxins produced by embryos; egg #s determine level of damage

Page 57: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Heterophyes, Metagonimus, continued

• Prevalence: high in oriental, asian and other countries where endemic, and cultural consumption of raw fish is common

• Diagnosis: microscopic ID of ova in feces via sedimentation concentration

• Treatment: nothing effective against systemically lodged ova; prazyquantel, tetrachloroethylene X adults

Page 58: MEDICAL PARASITOLOGY

Heterophyidae life cycle

Page 59: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Paragonimus westermani (lung fluke)

• Transmission: ingestion of metacercaria in crustacean secondary IH

• Pathogenic potential: moderate to high dependent on worm #s, species toxicity, level of tissue damage

• Clinical signs: none, fever, cough, bloody sputum, chest pain, bronchitis, dyspnea

• Reservoir: huge, almost any crustacean-eating mammal

• Damage potential: early migration through tissues minor; encapsulation in lungs major

Page 60: MEDICAL PARASITOLOGY

Flatworm helminths, continued

P. westermani, continued

• Prevalence: worldwide, dependent on human consumption of raw crustaceans

• Diagnosis: microscopic ID of ova in sputum or sedimentation-concentrated feces; ID of ova in needle biopsy of encapsulations in lungs

• Treatment: praziquantel, bithionol

Page 61: MEDICAL PARASITOLOGY

Paragonimus westermani life cycle

Page 62: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Fasciola hepatica (sheep, et.al., liver fluke)• Transmission: ingestion of metacercaria on

vegetation• Pathogenic potential moderate/high dependent

on worm #s & length of infection period• Clinical signs: none early, fever, chills, pain,

jaundice, eosinophilia, liver enlargement, other• Reservoir: huge, almost any herbivorous or

omnivorous animal is suitable host• Damage potential: moderate to high depending

on worm #s; migration through tissues & liver parenchyma, mechanical & toxic effects, hyperplasia of biliary epithelium, cirrhosis

Page 63: MEDICAL PARASITOLOGY

Flatworm helminths, continued

F. hepatica, continued

• Prevalence: millions of human infections probable, worldwide distribution dependent on aquatic vegetation production and consumption

• Diagnosis: microscopic ID of ova in fecal sedimentation

• Treatment: bithionol, praziquantel

Page 64: MEDICAL PARASITOLOGY

Fasciola hepatica life cycle

Page 65: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Clonorchis sinensis, Opisthorchis spp. (oriental liver flukes)

• Transmission: ingestion of metacercaria in fish secondary IH

• Pathogenic potential: 0 early, low/moderate late infection, depending on worm #s

• Clinical signs: similar to those described for F. hepatica, but usually less intense until worms reach very large population levels

• Reservoir: huge, nearly all piscivorous mammals in endemic areas

• Damage potential: moderate, similar but usually smaller magnitude than F. hepatica

Page 66: MEDICAL PARASITOLOGY

Flatworm helminths, continued

C. sinensis, O. spp., continued

• Prevalence: high in oriental & other countries where fish are eaten raw; sporadic in many countries, dependent on local cultural factors; some outbreaks tied to transport of fresh fish in non-endemic areas

• Diagnosis: microscopic ID of ova in feces processed by sedimentation concentration

• Treatment: praziquantel, albendazole

Page 67: MEDICAL PARASITOLOGY

Clonorchis/Opisthorchis life cycle

Page 68: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Dicrocoelium dendriticum (terrestrial liver fluke)

• Transmission: ingestion of metacercaria in ant secondary IH; primary IH is a terrestrial snail/slug

• This agent is mentioned only to provide an example of adaptability, and is confined to warm, moist areas of the world where gastropod secondary IHs mingle with scavenging, arthropod-ingesting DHs; most of the internal factors described for other liver flukes are applicable to D. dendriticum

Page 69: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Schistosomes/Bloodflukes

Generalized schistosomal life cycle

Male & Female Adults in DH

Egg Miracidium embryo Snail IH

Sporocyst larvae

Cercaria

Page 70: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Schistosoma mansoni, S. japonicum, S. haematobium (blood flukes)

• Transmission: direct penetration of skin by fork-tailed cercaria in water

• Pathogenic potential: high, based on worm populations and location in veins, capability of eggs to erode tissue, other

• Clinical signs: none early or if worm #s low, transient skin reaction at entry, malaise, fever, skin rashes, cough, acute hepatitis, abcesses, hepatomegaly, cardiomyopathy, haematuria

• Reservoir: limited?, monkeys, rodents, humans

Page 71: MEDICAL PARASITOLOGY

Flatworm helminths, continued

S. mansoni, S. japonicum, S. haematobium, continued

• Damage potential high, dependent on location of adults, excretions of adults and miracidia in ova, population #s, egg locations & #s, damage is accumulative over time

• Prevalence: distribution worldwide in tropical, subtropical, temperate regions; human infections nearly equal to prevalence of malaria,

• Diagnosis: microscopic ID of ova in feces, urine or biopsy specimen

• Treatment: praziquantel, oxamniquin, bilarcil

Page 72: MEDICAL PARASITOLOGY

Schistosoma species life cycle

Page 73: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Shistosoma spp.

• Transmission: cercarial penetration of skin in water

• This group of schistosomes do not develop to adulthood in humans. They are parasites of birds and other animals, but will infect humans when in contact in water. They cause a cutaneous larval migrans referred to as “swimmers itch”, which is transitory and usually eliminated by the immune response

Page 74: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Generalized Pseudophyllidean Life Cycle

Adults in DH SIEgg Coracidium

Procercoid larva Copepod primary IH

Plerocercoid larva Fish secondary IH

Adults in DH SI

Page 75: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Pseudophyllidean tapeworms

Diphyllobothrium latum (broad fish tapeworm)

• Transmission: ingestion of plerocercoid larva in uncooked fish

• Pathogenic potential: low, dependent on host sensitivity, location of worm in SI

• Clinical signs: usually none, pernicious anemia if worm is anchored near pyloric sphincter

• Reservoir hosts: various wild & domestic fish-eating mammals; dogs, cats, bears, seals, other

• Damage potential low: strong affinity for B12

Page 76: MEDICAL PARASITOLOGY

Flatworm helminths, continued

D. latum, continued

• Prevalence worldwide, where freshwater or brackish water fish are consumed raw

• Diagnosis: observation of proglottid chains in stools; microscopic ID of ova in feces

• Treatment: prazyquantel, niclosamide

Page 77: MEDICAL PARASITOLOGY

Pseudophyllidean (Diphyllobothrium latum) life cycle

Page 78: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Generalized Cyclophyllidean Life Cycle

Adults in DH SI

Egg with Onchosphere/Hexacanth Embryo

Larva (Cysticercoid, cysticercus, coenurus, hydatid) in IH

Adults in DH SI

Page 79: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Cyclophyllidian tapewormsTaenia solium (pork tapeworm)• Transmitted by ingestion of cysticercus larvae

in uncooked pork (adult worm in SI); ingestion of TW eggs in human fecal contamination (cysticercus/larval development in tissues)

• Pathogenic potential: low as adult in SI; low/moderate as larvae in tissues

• Clinical signs: usually none with adult infection, dependent on location with larval infection

• Reservoir hosts: humans and pigs• Damage potential 0 to low with adults,

low/moderate with larvae, location dependent

Page 80: MEDICAL PARASITOLOGY

Flatworm helminths, continued

T. solium, continued

• Prevalence: worldwide, where humans and pigs interact, and pork is eaten raw

• Diagnosis: observation of proglottid chains in stool for adult worms; biopsy removal of larva from tissue site, microscopic ID of hooklets in a crush mount

• Treatment: prazyquantel, niclosamide X adults; albendazole somewhat effective X cysticerci, untreated larval infections often subside (symptom-wise) within 2 to 5 years

Page 81: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Taenia saginata (beef tapeworm)

• Transmission by ingestion of cysticercus larva in fresh, raw beef

• Pathogenic potential 0/low

• Clinical signs: none, usually

• Reservoir hosts: bovine IHs, human DHs

• Damage potential 0/low

• Prevalence worldwide, wherever beef is eaten raw and cattle are exposed to human feces

• Diagnosis: sight of proglottid chains in stool

• Treatment: prazyquantel, niclosamide

Page 82: MEDICAL PARASITOLOGY

Taenia species life cycle

Page 83: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Hymenolepis nana, H. diminuta, Dipyllidium caninum, others

• Transmission: ingestion of arthropod IH host containing cysticercoid larva

• Pathogenic potential 0/very low

• Clinical signs: usually none, sensitive DH may show diarrhea, headache, abdominal pain, dizziness, anorexia, other nonspecific signs

• Reservoir hosts: rodents, dogs, “normal” DHs

• Damage potential 0/very low

• Prevalence world-wide, dependent on distribution of “normal” DHs

Page 84: MEDICAL PARASITOLOGY

Flatworm helminths, continued

H. nana, H. diminuta, D. caninum, continued

• Diagnosis complicated by small size of worms, making their observation in stools difficult; eggs may sometimes be observed in fecal flotation examinations

• Treatment: prazyquantel, niclosamide

Page 85: MEDICAL PARASITOLOGY

Hymenolepis nana life cycle

Page 86: MEDICAL PARASITOLOGY

Hymenolepis diminuta life cycle

Page 87: MEDICAL PARASITOLOGY

Dipyllidium caninum life cycle

Page 88: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Larval Tapeworm Infections

Echinococcus granulosus, E. multilocularis (unilocular/multilocular hydatidosis respectively)

• Transmission: ingestion of ova in feces of DH• Pathogenic potential high, dependent on larval

type and organ involved• Clinical signs dependent on size of cyst, organ

location: related to pressure, abrasion, other• Reservoir hosts: DH carnivores/omnivores, IH

prey species primarily herd animals (sheep, etc)• Damage potential dependent on organ location,

size of cyst; moderate to high

Page 89: MEDICAL PARASITOLOGY

Flatworm helminths, continued

E. granulosus, E. multilocularis, continued

• Prevalence in humans spotty, dependent on human interaction with canine DH and herbivore IH; distribution world-wide from equator to arctic, wherever predator-prey activity occurs (everywhere?)

• Diagnosis: microscopic ID of protoscoleces from needle biopsy of cyst, X-ray/other image detection of cyst in organ (liver, lung, brain, other); skin test, serotest

• Treatment: Surgical removal of cyst (unilocular), albendazole somewhat (variably) effective

Page 90: MEDICAL PARASITOLOGY

Echinococcus species life cycle

Page 91: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Taenia spp. of carnivores

• Transmission: ingestion of eggs in DH feces

• Pathogenic potential low to moderate, dependent on host sensitivity, #s & location of cysticerci in IH (human)

• Clinical signs: none, CNS-related abnormalities, subcutaneous nodules, et.al., site dependent

• Reservoir hosts: DH carnivores, IH prey

• Damage potential: dependent on worm species, larva type (cysticercus or coenurus), larva location; host sensitivity, number of larvae

Page 92: MEDICAL PARASITOLOGY

Flatworm helminths, continued

Taenia spp., continued

• Prevalence; worldwide, equator to arctic in normal carnivore DHs, prey IHs, spotty, somewhat infrequent/rare in humans

• Diagnosis: microscopic ID of larval biopsy

• Treatment: albendazole somewhat effective-seldom/never 100% curative

Page 93: MEDICAL PARASITOLOGY

Cysticercosis-causing tapeworm life cycle